Cargando…
Asymmetry indicates more severe and active disease in Graves’ orbitopathy: results from a prospective cross-sectional multicentre study
PURPOSE: Patients with Graves’ orbitopathy can present with asymmetric disease. The aim of this study was to identify clinical characteristics that distinguish asymmetric from unilateral and symmetric Graves’ orbitopathy. METHODS: This was a multi-centre study of new referrals to 13 European Group o...
Autores principales: | Perros, P., Žarković, M. P., Panagiotou, G. C., Azzolini, C., Ayvaz, G., Baldeschi, L., Bartalena, L., Boschi, A. M., Nardi, M., Brix, T. H., Covelli, D., Daumerie, C., Eckstein, A. K., Fichter, N., Ćirić, S., Hegedüs, L., Kahaly, G. J., Konuk, O., Lareida, J. J., Okosieme, O. E., Leo, M., Mathiopoulou, L., Clarke, L., Menconi, F., Morris, D. S., Orgiazzi, J., Pitz, S., Salvi, M., Muller, I., Knežević, M., Wiersinga, W. M., Currò, N., Dayan, C. M., Marcocci, C., Marinò, M., Möller, L., Pearce, S. H., Törüner, F., Bernard, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652741/ https://www.ncbi.nlm.nih.gov/pubmed/32474767 http://dx.doi.org/10.1007/s40618-020-01258-w |
Ejemplares similares
-
Graves’ orbitopathy as a rare disease in Europe: a European Group on Graves’ Orbitopathy (EUGOGO) position statement
por: Perros, P., et al.
Publicado: (2017) -
Management of Graves’ hyperthyroidism and orbitopathy in time of COVID-19 pandemic
por: Bartalena, L., et al.
Publicado: (2020) -
Effects of treatment modalities for Graves’ hyperthyroidism on Graves’ orbitopathy: a 2015 Italian Society of Endocrinology Consensus Statement
por: Bartalena, L., et al.
Publicado: (2015) -
Anti-nuclear autoantibodies in Graves’ disease and Graves’ orbitopathy
por: Lanzolla, G., et al.
Publicado: (2022) -
Sirolimus as a second-line treatment for Graves’ orbitopathy
por: Lanzolla, G., et al.
Publicado: (2022)